Literature DB >> 14016287

[Clinical experience with a test of pituitary reserve].

J BRUNET, G SAUCIER.   

Abstract

A test of pituitary reserve was used in the investigation of 14 children with retarded growth and 15 adults with endocrine disorders. Mepyrapone (Metopiron), 500 mg. every four hours, was administered orally for 48 hours. The pituitary response was determined by the amount of 17-hydroxycorticosteroid in a 24-hour urine sample (by a modification by Peterson of the Porter-Silber method). Pituitary reserve was decreased in four patients who were pituitary dwarfs, one who had retarded growth, two patients with Sheehan's syndrome, three with pituitary tumours, one who had panhypopituitarism without a tumour, and one case of limited adrenal reserve (confirmed by a negative response to ACTH stimulation). The pituitary reserve was normal in three patients with gonadal dysgenesis, three who exhibited retarded growth, one case of diabetes insipidus, one cretin, one patient treated by steroids, three with psychogenic amenorrhea, and five normal controls. It is concluded that this test of pituitary reserve is useful in the assessment of children with growth retardation and in establishing the diagnosis of pituitary insufficiency in adults.

Entities:  

Keywords:  HYPOPITUITARISM

Mesh:

Substances:

Year:  1963        PMID: 14016287      PMCID: PMC1921739     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  Metopirone in the assessment of pituitary-adrenal function.

Authors:  A C BROWNIE; J G SPRUNT
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

2.  Decreased corticotropin reserve as isolated pituitary defect.

Authors:  W L GREEN; S H INGBAR
Journal:  Arch Intern Med       Date:  1961-12

3.  Quantitation of pituitary corticotropin reserve in man by use of an adrenocortical 11-beta hydroxylase inhibitor (SU-4885).

Authors:  E M GOLD; V C DIRAIMONDO; P H FORSHAM
Journal:  Metabolism       Date:  1960-01       Impact factor: 8.694

4.  Evaluation of pituitary-adrenocortical function in patients with rheumatoid arthritis following steroid therapy.

Authors:  J W MEAKIN; M S TANTONGCO; J CRABBE; T B BAYLES; D H NELSON
Journal:  Ann N Y Acad Sci       Date:  1960-06-30       Impact factor: 5.691

5.  Hypoadrenotropism: the isolated deficiency of adrenotropic hormone.

Authors:  W D ODELL; M D GARETH; G M GREEN; R H WILLIAMS
Journal:  J Clin Endocrinol Metab       Date:  1960-07       Impact factor: 5.958

6.  Selective hypopituitarism with deficiency of anterior pituitary basophils: a case report.

Authors:  G T PERKOFF; K EIK-NES; W H CARNES; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1960-09       Impact factor: 5.958

7.  Clinical use of a new diagnostic agent, methopyrapone (SU-4885), in pituitary and adrenocortical disorders.

Authors:  E M GOLD; J R KENT; P H FORSHAM
Journal:  Ann Intern Med       Date:  1961-02       Impact factor: 25.391

8.  [A new test for exploration of the pituitary gland: the metopyrone or SU 4885 test].

Authors:  B de FOSSEY; H BRICAIRE
Journal:  Presse Med       Date:  1961-09-16       Impact factor: 1.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.